FOR IMMEDIATE RELEASE
August 2, 2013
Phone: (703) 879-3822
Same Leaders, New Leadership Structure
The Meso Foundation has a new leadership structure. Mary Hesdorffer, NP and Melinda Kotzian have been sharing leadership responsibilities since August of 2012, with Ms. Hesdorffer focusing on research and science activities and Ms. Kotzian focusing on the business side of the organization.
Effective immediately, Melinda Kotzian, who has thus far been the Chief Operating Officer, will now serve as the Foundation’s first Chief Executive Officer. This change in title provides Ms. Kotzian with full authority to act as an officer of the Foundation. Despite this change in title, the actual leadership structure will not change. Ms. Hesdorffer and Ms. Kotzian will continue sharing executive duties as they have been for the past year.
“I’m thrilled that Melinda’s title is finally in sync with her responsibilities,” said Mary Hesdorffer, NP, Meso Foundation’s executive director. “She has been working hard on behalf of the Foundation and this change will help her do even more,” she added.
Melinda Kotzian has been with the Meso Foundation since 2010. Prior to working at the Meso Foundation, she was at the Naomi and Nehemiah Cohen Foundation , a small family foundation in the Washington, DC area which works on issues of social justice and helping those in need. Ms. Kotzian is a member of the Grants Management Network, Center for Nonprofit Advancement and the Nonprofit Professionals Network DC.
ABOUT THE MESOTHELIOMA APPLIED RESEARCH FOUNDATION
The Meso Foundation is the only 501(c)3 non-profit organization dedicated to eradicating mesothelioma and easing the suffering caused by it. The Meso Foundation actively seeks philanthropic support to fund peer-reviewed mesothelioma research; provide patient support services and education; and advocate Congress for increased federal funding for mesothelioma research. The Meso Foundation is the only non-government funder of peer reviewed scientific research to establish more effective treatments for mesothelioma and, ultimately, a cure for this rare, but extremely aggressive, cancer. To date, the Foundation has awarded over $8.2 million to research.
More information is available at www.curemeso.org.